Evidence map›Paper›PMID 23233447›Full record

ArticleMolecular & cellular proteomics : MCP2013

A high-throughput assay for phosphoprotein-specific phosphatase activity in cellular extracts.

Anjun K Bose, Kevin A Janes

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Science advances · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anjun K BoseDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.
Kevin A Janes
University of Virginia · US

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Thomas P. Loughran · 1987 to 2026
$72.1M
Stochastic Control of Abnormal Morphogenesis Induced by the ErbB2 OncoproteinDP2OD006464 · OD · UNIVERSITY OF VIRGINIA · PI JANES, KEVIN A · 2009 to 2009
$2.3M
NCI NIH HHS P30 CA044579NIH HHS 1-DP2-OD006464NIH HHS DP2 OD006464
6 · The paper itself

Abstract

Protein phosphatases undo the post-translational modifications of kinase-signaling networks, but phosphatase activation in cells is difficult to measure and interpret. Here, we report the design of a quantitative and high-throughput assay platform for monitoring cellular phosphatase activity toward specific phosphoprotein targets. Protein substrates of interest are purified recombinantly, phosphorylated in vitro using the upstream kinase, and adsorbed to 96-well plates. Total phosphatase extracts from cells are then added to trigger a solid-phase dephosphorylation reaction. After stopping the reaction, phosphoprotein levels are quantified by ELISA with a phospho-specific antibody, and the loss of phospho-specific immunoreactivity is used as the readout of phosphatase activity. We illustrate the generality of the method by developing specific phosphatase-activity assays for the three canonical mitogen-activated protein phospho-kinases: ERK, JNK, and p38. The assays capture changes in activity with a dynamic range of 25-100-fold and are sensitive to a limit of detection below 25,000 cells. When applied to cytokine-induced signaling, the assays revealed complex and dynamic regulation of phosphatases suggesting cross-communication and a means for cellular memory. Our assay platform should be beneficial for phosphoproteomic surveys and computational-systems models of signaling, where phosphatases are known to be important but their activities are rarely measured.

Indexed as

Cell ExtractsAnimalsBlotting, WesternDual-Specificity PhosphatasesEnzyme ActivationEnzyme AssaysEnzyme-Linked Immunosorbent AssayEpidermal Growth FactorHT29 CellsHumansInterferon-gammaMiceMitogen-Activated Protein Kinase PhosphatasesMitogen-Activated Protein KinasesPhosphoprotein PhosphatasesPhosphoproteinsCell ExtractsDual-Specificity PhosphatasesDUSP10 protein, humanDUSP16 protein, humanEpidermal Growth FactorInterferon-gammaMitogen-Activated Protein Kinase PhosphatasesMitogen-Activated Protein KinasesPhosphoprotein PhosphatasesPhosphoproteinsTumor Necrosis Factor-alpha

Identifiers

PMID23233447
PMCPMC3591670
OpenAlexW2149299946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.